Aurora Spine Stock Net Income
| ASAPF Stock | USD 0.20 0.01 5.26% |
As of the 23rd of January, Aurora Spine shows the Mean Deviation of 2.56, insignificant risk adjusted performance, and Standard Deviation of 4.14. Aurora Spine technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Aurora Spine, which can be compared to its peers. Please confirm Aurora Spine information ratio and potential upside to decide if Aurora Spine is priced correctly, providing market reflects its regular price of 0.2 per share. As Aurora Spine appears to be a penny stock we also recommend to validate its jensen alpha numbers.
Aurora Spine's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Aurora Spine's valuation are provided below:Aurora Spine does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Aurora |
Aurora Spine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aurora Spine's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aurora Spine.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Aurora Spine on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Aurora Spine or generate 0.0% return on investment in Aurora Spine over 90 days. Aurora Spine is related to or competes with Biotricity, Guided Therapeutics, and Cell Source. Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of min... More
Aurora Spine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aurora Spine's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aurora Spine upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 20.53 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 5.56 |
Aurora Spine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aurora Spine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aurora Spine's standard deviation. In reality, there are many statistical measures that can use Aurora Spine historical prices to predict the future Aurora Spine's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (0.06) |
Aurora Spine January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 2.56 | |||
| Coefficient Of Variation | (6,917) | |||
| Standard Deviation | 4.14 | |||
| Variance | 17.17 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 20.53 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 5.56 | |||
| Skewness | 0.1852 | |||
| Kurtosis | 0.9225 |
Aurora Spine Backtested Returns
Aurora Spine secures Sharpe Ratio (or Efficiency) of -0.0378, which signifies that the company had a -0.0378 % return per unit of risk over the last 3 months. Aurora Spine exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aurora Spine's Standard Deviation of 4.14, mean deviation of 2.56, and insignificant Risk Adjusted Performance to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.21, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aurora Spine will likely underperform. At this point, Aurora Spine has a negative expected return of -0.15%. Please make sure to confirm Aurora Spine's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Aurora Spine performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.08 |
Virtually no predictability
Aurora Spine has virtually no predictability. Overlapping area represents the amount of predictability between Aurora Spine time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aurora Spine price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Aurora Spine price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Aurora Spine reported net income of (2.36 Million). This is 100.69% lower than that of the Healthcare sector and 100.99% lower than that of the Medical Devices industry. The net income for all United States stocks is 100.41% higher than that of the company.
Aurora Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aurora Spine's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Aurora Spine could also be used in its relative valuation, which is a method of valuing Aurora Spine by comparing valuation metrics of similar companies.Aurora Spine is currently under evaluation in net income category among its peers.
Aurora Fundamentals
| Return On Equity | -0.27 | |||
| Return On Asset | -0.0851 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.10) % | |||
| Current Valuation | 25.13 M | |||
| Shares Outstanding | 66.73 M | |||
| Shares Owned By Insiders | 17.89 % | |||
| Price To Book | 4.22 X | |||
| Price To Sales | 1.70 X | |||
| Revenue | 10.54 M | |||
| Gross Profit | 4.83 M | |||
| EBITDA | (1.9 M) | |||
| Net Income | (2.36 M) | |||
| Cash And Equivalents | 758.98 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 2.27 M | |||
| Debt To Equity | 0.58 % | |||
| Current Ratio | 2.43 X | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (2.13 M) | |||
| Earnings Per Share | (0.04) X | |||
| Beta | 0.53 | |||
| Market Capitalization | 21.68 M | |||
| Total Asset | 10.56 M | |||
| Z Score | 5.4 | |||
| Net Asset | 10.56 M |
About Aurora Spine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aurora Spine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aurora Spine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aurora Spine based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Aurora OTC Stock
Aurora Spine financial ratios help investors to determine whether Aurora OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aurora with respect to the benefits of owning Aurora Spine security.